Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice

被引:182
作者
Vlaming, Maria L. H. [1 ]
Lagas, Jurjen S. [1 ]
Schinkel, Alfred H. [1 ]
机构
[1] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands
关键词
BCRP/Bcrp1; Blood-brain barrier; Blood-placental barrier; Blood-testis barrier; Blood-retinal barrier; Mammary gland; Vitamin transport; Harderian gland; Porphyrins; Phytoestrogens; CANCER RESISTANCE PROTEIN; BLOOD-BRAIN-BARRIER; LIMITS FETAL DISTRIBUTION; P-GLYCOPROTEIN; MILK SECRETION; IN-VIVO; EFFLUX TRANSPORTERS; PROTOPORPHYRIN-IX; DRUG TRANSPORTERS; HARDERIAN-GLAND;
D O I
10.1016/j.addr.2008.08.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The multidrug transporter ABCG2 (BCRP/MXR/ABCP) can actively extrude a broad range of endogenous and exogenous substrates across biological membranes. ABCG2 limits oral availability and mediates hepatobiliary and renal excretion of its substrates, and thus influences the pharmacokinetics of many drugs. Recent work. relying mainly on the use of Abcg2(-/-) mice, has revealed important contributions of ABCG2 to the blood-brain, blood-testis and blood-fetal barriers. Together, these functions indicate a primary biological role of ABCG2 in protecting the organism from a range of xenobiotics. In addition, several other physiological functions of ABCG2 have been observed. including extrusion of porphyrins and/or porphyrin conjugates from hematopoietic cells, liver and harderian gland, as well as secretion of vitamin B-2 (riboflavin) and possibly other vitamins (biotin, vitamin K) into breast milk. However, the physiological significance of these processes has been difficult to establish, indicating that there is still a lot to learn about this intriguing protein. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 25
页数:12
相关论文
共 67 条
  • [1] 17β-estradiol and environmental estrogens significantly affect mammalian sperm function
    Adeoya-Osiguwa, SA
    Markoulaki, S
    Pocock, V
    Milligan, SR
    Fraser, LR
    [J]. HUMAN REPRODUCTION, 2003, 18 (01) : 100 - 107
  • [2] Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta
    Aleksunes, Lauren M.
    Cui, Yue
    Klaassen, Curtis D.
    [J]. DRUG METABOLISM AND DISPOSITION, 2008, 36 (09) : 1960 - 1970
  • [3] ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells
    Asashima, Tomoko
    Hori, Satoko
    Ohtsuki, Sumio
    Tachikawa, Masanori
    Watanabe, Masahiko
    Mukai, Chisato
    Kitagaki, Shinji
    Miyakoshi, Naoki
    Terasaki, Tetsuya
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (06) : 1235 - 1242
  • [4] The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
    Assaraf, Yehuda G.
    [J]. DRUG RESISTANCE UPDATES, 2006, 9 (4-5) : 227 - 246
  • [5] The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours
    Bart, J
    Hollema, H
    Groen, HJM
    de Vries, EGE
    Hendrikse, NH
    Sleijfer, DT
    Wegman, TD
    Vaalburg, W
    van der Graaf, WTA
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (14) : 2064 - 2070
  • [6] Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier
    Bihorel, Sebastien
    Camenisch, Gian
    Lemaire, Michel
    Scherrmann, Jean-Michel
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 (06) : 1749 - 1757
  • [7] Anticonvulsant hypersensitivity syndrome: Implications for pharmaceutical care
    Bohan, KarenBeth H.
    Mansuri, Tarannum F.
    Wilson, Natalie M.
    [J]. PHARMACOTHERAPY, 2007, 27 (10): : 1425 - 1439
  • [8] Retinal photodamage
    Boulton, M
    Rózanowska, M
    Rózanowski, B
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 64 (2-3) : 144 - 161
  • [9] The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients
    Breedveld, P
    Pluim, D
    Cipriani, G
    Wielinga, P
    van Tellingen, O
    Schinkel, AH
    Schellens, JHM
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2577 - 2582
  • [10] The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models
    Breedveld, Pauline
    Pluim, Dick
    Cipriani, Greta
    Dahlhaus, Femke
    van Eijndhoven, Maria A. J.
    de Wolf, Cornelia J. F.
    Kuil, Annemieke
    Beijnen, Jos H.
    Scheffer, George L.
    Jansen, Gerrit
    Borst, Piet
    Schellens, Jan H. M.
    [J]. MOLECULAR PHARMACOLOGY, 2007, 71 (01) : 240 - 249